Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-13

Clinical Trial Update: Biomarkers For Immune Checkpoint Inhibitors

View source ↗

Summary

This clinical trial update reports the completion of a study investigating biomarkers associated with response to immune checkpoint inhibitors in advanced cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Immune checkpoint inhibitors (class)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Advanced Cancer, Neoplasms | Status: COMPLETED